Extended-Spectrum β-lactamase-Producing Escherichia coli in Retail Pork and Market Environments: Genetic Diversity and Antimicrobial Resistance in Thailand
Foodborne Pathogens and Disease · 01.08.2026 · 23 (8) · 524-531
DOI: 10.1089/fpd.2025.0045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foodborne Pathogens and Disease, online erschienen am 09.07.2025. Verfasst von Sutsiree Intongead und 6 weiteren Autor:innen. Beteiligte Einrichtung: Akkhraratchakumari Veterinary College, Walailak University, Nakhon Si Thammarat, Thailand. Hauptthemen laut MEDLINE: Escherichia coli, beta-Lactamases, Genetic Variation, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
The increasing prevalence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli ( E. coli ) highlights the growing issue of multidrug resistance within the food processing chain. This study aimed to determine the prevalence, antimicrobial resistance profiles, molecular genetic structures, and genetic diversity of ESBL-producing E. coli isolated from pork, cutting boards, and knives. A total of 90 samples were collected from 10 local markets in Southern Thailand. ESBL-producing E. coli were identified in 9 samples (10%), with knife samples showing the highest contamination rate (5/90, 5.55%). The ESBL-producing E. coli isolates exhibited high-level resistance to ampicillin (100%), ceftriaxone (88.89%), and cefpodoxime (88.89%), followed by tetracycline (77.78%). Multidrug resistance was detected in 88.89% (8/9) of ESBL-producing E. coli isolates and 28.26% (13/46) of all E. coli isolates. All presumptive ESBL-producing isolates carried ESBL resistance genes (9/9, 100%), with bla CTX-M-1 being the most prevalent (6/9, 66.67%). Additionally, the tetA gene was frequently detected in ESBL-producing E. coli (6/9, 66.67%) and in all E. coli isolates (16/46, 34.78%). Overall, E. coli O157:H7 was identified in 5 isolates (10.87%). The genetic relatedness analysis revealed that five ESBL-producing E. coli isolates were closely related to E. coli ATCC 23502. Our findings confirm a high prevalence of ESBL-producing E. coli carrying resistance genes in knife samples, underscoring the importance of proper sanitary handling practices to minimize microbial contamination in pork retail shops.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Akkhraratchakumari Veterinary College, Walailak University, Nakhon Si Thammarat, Thailand.
- One Health Research Center, Walailak University, Nakhon Si Thammarat, Thailand.
- School of Veterinary Medicine Laboratory of Public Health II, Azabu University, Kanagawa, Japan.
- Center of Excellence in Innovation of Essential Oil, Walailak University, Nakhon Si Thammarat, Thailand.
ORCID-Profile: Ratchadaporn Boripun
Zitieren
APA
Intongead, S., Saengsawang, P., Boonmar, S., Morita, Y., Mitsuwan, W., Narinthorn, R., & Boripun, R. (2026). Extended-Spectrum β-lactamase-Producing Escherichia coli in Retail Pork and Market Environments: Genetic Diversity and Antimicrobial Resistance in Thailand. Foodborne Pathogens and Disease, 23(8), 524-531. https://doi.org/10.1089/fpd.2025.0045
Vancouver
Intongead S, Saengsawang P, Boonmar S, Morita Y, Mitsuwan W, Narinthorn R, et al. Extended-Spectrum β-lactamase-Producing Escherichia coli in Retail Pork and Market Environments: Genetic Diversity and Antimicrobial Resistance in Thailand. Foodborne Pathogens and Disease. 2026;23(8):524-531. doi:10.1089/fpd.2025.0045
BibTeX
@article{Intongead2026,
author = {Intongead, Sutsiree and Saengsawang, Phirabhat and Boonmar, Sumalee and Morita, Yukio and Mitsuwan, Watcharapong and Narinthorn, Ruethai and Boripun, Ratchadaporn},
title = {Extended-Spectrum β-lactamase-Producing Escherichia coli in Retail Pork and Market Environments: Genetic Diversity and Antimicrobial Resistance in Thailand},
journal = {Foodborne Pathogens and Disease},
year = {2026},
volume = {23},
number = {8},
pages = {524--531},
doi = {10.1089/fpd.2025.0045}
}
EUVIMED